Immunome, Inc.
IMNM
$18.44
$0.050.27%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/10/2026
-
The Cerbat Gem
6/9/2026
-
SeekingAlpha
6/9/2026
-
SeekingAlpha
6/9/2026
-
Seeking Alpha - Healthcare
6/7/2026
-
Simply Wall St
6/5/2026
-
Zacks Investment Research
6/5/2026
-
Tickeron - Stocks
6/4/2026
-
Business Wire
6/4/2026
-
Tickeron - Stocks
6/4/2026
-
Tickeron - Stocks
6/4/2026
-
TipRanks Financial Blog
6/1/2026
-
TipRanks Financial Blog
6/1/2026
-
TipRanks Financial Blog
5/31/2026
-
Simply Wall St
5/30/2026
-
GuruFocus
5/30/2026
-
Business Wire
5/29/2026
-
Simply Wall St
5/29/2026
-
Tickeron - Stocks
5/29/2026
-
Tickeron - Stocks
5/28/2026
-
TipRanks Financial Blog
5/27/2026
-
GuruFocus
5/27/2026
-
Business Wire
5/24/2026
-
Tickeron - Stocks
5/23/2026
-
Tickeron - Stocks
5/22/2026
-
The Cerbat Gem
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 12, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
425 939 7410
Address
18702 North Creek Parkway
Bothell, WA 98011
Bothell, WA 98011
Country
Year Founded
Business Description
Sector
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the...
more